News

Laureate Pharma (Laureate) has signed a new biopharmaceutical development and manufacturing agreement with an undisclosed client. According to the agreement, Laureate will develop the process to manufacture a

Sinobiopharma has reported revenue of $1.29m for three months period which ended August 31, 2009, an increase of 39% from $931,203 for the comparable period previous year. Gross

The National Institute for Health and Clinical Excellence (NICE) has issued its Appraisal Consultation Document (ACD) rejecting oral Tyverb (lapatinib) in combination with capecitabine for the treatment of

Endocyte has presented data from a phase 2a clinical trial for EC145, currently in development as a potential treatment for advanced ovarian cancer. Results were presented at the

ISTA Pharmaceuticals has announced poster presentations of results from its Bepreve (bepotastine besilate ophthalmic solution) 1.5% phase 3 clinical studies in allergic conjunctivitis. The studies demonstrated that Bepreve

The US Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) has recommended that GlaxoSmithKline’s (GSK) Cervarix be given to girls and young women

Novavax and Xcellerex have entered into a strategic collaboration to accelerate the development of Novavax’s vaccine manufacturing process to commercial scale and begin immediate production of Novavax’s novel

APP Pharmaceuticals (APP), a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals, has received approval from the FDA to market Chlorothiazide Sodium for Injection, USP. APP expects to launch

Entest BioMedical has signed a letter of intent to acquire Therinject. Therinject is involved with Cancer Research, marker testing/development and ‘bead’ formation used in vaccine development. The company